109
Participants
Start Date
January 11, 2021
Primary Completion Date
December 28, 2021
Study Completion Date
March 3, 2022
RDX013
RDX013 is an experimental drug that is a potassium secretagogue
Placebo
Placebo treatment that looks identical to experimental treatment
Mountain Kidney & Hypertension Associates, Asheville
Panax Clinical Research LLC, Miami Lakes
Horizon Research Group LLC, Coral Gables
South Florida Research Phase I-IV; Inc., Miami Springs
Clinical Research Consultants, Kansas City
NW Louisiana Nephrology Assoc, Shreveport
Lead Sponsor
Ardelyx
INDUSTRY